Eli Lilly stock also has a Composite Rating of 82, a measure of fundamental and technical metrics. Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on artificial intelligence, ...

The 27th annual All-Brazos Valley Volleyball Team was all about parity, and it’s not hard to see why after the amount of deep playoff runs that the area had this season. 14 different schools ...

an actor with Max Reinhardt’s troupe, really was a vampire. Director Robert Eggers, actor Emma Corrin, director of photography Jarin Blaschke and actors Lily-Rose Depp and Aaron Taylor-Johnson ...

BLOOMINGTON — Starting lineup introductions were more dramatic than usual Thursday for the first girls semifinal of the ...

In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...

Both Lilly and Novo Nordisk are experiencing unprecedented growth thanks to their weight loss medications. However, Lilly also treats cancer, plaque psoriasis, Alzheimer's disease, eczema ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...